The role of therapy in the outcome of patients with myelofibrosis.
Lucia MasarovaPrithviraj BoseNaveen PemmarajuNaval G DaverKoiji SasakiHelen T ChifotidesLingsha ZhouHagop M KantarjianZeev EstrovSrdan VerstovsekPublished in: Cancer (2023)
This study demonstrated improved outcomes of patients with MF who received treatment with the JAK inhibitor ruxolitinib.